Blueprint Medicines Research and Development Expenses 2014-2025 | BPMC

Blueprint Medicines research and development expenses for the twelve months ending March 31, 2025 were $0.345B, a 14.54% decline year-over-year.

  • Blueprint Medicines annual research and development expenses for 2024 were $0.341B, a 20.17% decline from 2023.
  • Blueprint Medicines annual research and development expenses for 2023 were $0.428B, a 10.41% decline from 2022.
  • Blueprint Medicines annual research and development expenses for 2022 were $0.477B, a 20.57% decline from 2021.

Blueprint Medicines Research and Development Expenses 2014-2025 | BPMC

  • Blueprint Medicines annual research and development expenses for 2024 were $0.341B, a 20.17% decline from 2023.
  • Blueprint Medicines annual research and development expenses for 2023 were $0.428B, a 10.41% decline from 2022.
  • Blueprint Medicines annual research and development expenses for 2022 were $0.477B, a 20.57% decline from 2021.